Hosted on MSN1mon
10x Genomics sees robust growth across platforms in Q4 2023
10x Genomics delivered strong Q4 2023 results with substantial contributions from Xenium and Visium platforms. As the company enters 2024, its focus on expanding product adoption while managing ...
Fox 5 San Diego1mon
10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
The forthcoming Visium HD 3' assay is a reverse transcription ... sections at single-cell-scale resolution. Xenium RNA+Protein Multiomics: 10x Genomics shared plans to enable simultaneous ...
Seeking Alpha18d
10x Genomics: Lower Cost Innovation May Drive A Rebound
Founded in 2012, 10x Genomics (NASDAQ ... Its Chromium platform allows for single-cell analysis, while its Visium and Xenium enable spatial analysis. Since TXG has largely been known as a pioneer ...
Seeking Alpha5mon
TXG 10x Genomics, Inc.
10x Genomics, Inc., a life science technology ... of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve ...
Stockhouse1mon
10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
The company also highlighted Visium HD XL, which will feature an expanded capture area to enable whole transcriptome spatial gene expression analysis of larger tissue sections at single-cell-scale ...
Nasdaq1mon
10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
These capabilities will be available to support both the Chromium and Visium platforms ... tissue organization and function. Xenium RNA+Protein Multiomics: 10x Genomics shared plans to enable ...